{
    "clinical_study": {
        "@rank": "124548", 
        "arm_group": [
            {
                "arm_group_label": "Homeopathy", 
                "arm_group_type": "Experimental", 
                "description": "A range of homeopathic potencies were used as per the individualized  requirement, decided by the treating physicians.Each dose, administered orally,  (in centesimal potencies)."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo, identical in appearance, consisted of   83.1% ethanol in 10 ml distilled water and was served in identical amber-coloured glass vials"
            }
        ], 
        "brief_summary": {
            "textblock": "Resistant hypertension (RHTN)  is a common clinical problem faced by both primary care\n      clinicians and specialists worldwide. Patients with RHTN have higher rates of cardiovascular\n      events and mortality compared with patients with more easily controlled hypertension. In\n      addition, RHTN is often complicated by metabolic abnormalities.\n\n      Homeopathy, although widely used in hypertension, but no study has been taken to evaluate\n      the impact on resistant hypertension. The aim of this trial was to evaluate  individualized\n      homeopathy on BP in patients with resistant  hypertension."
        }, 
        "brief_title": "Addition of Homeopathy in Patients With Resistant Arterial Hypertension", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Hypertension, Resistant to Conventional Therapy", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients older than 18 years with resistant arterial hypertension.\n\n          -  Office systolic BP >140 mm Hg or diastolic BP >90 mm Hg despite being treated with at\n             least 3 antihypertensive drugs, including a diuretic.\n\n          -  Patients with diabetes or chronic kidney disease (defined as serum creatinine   >133\n             \u03bcmol/L or proteinuria >300 mg/day) if the office BP was >130/80 mm Hg.\n\n        Exclusion Criteria:\n\n          -  Severe hypertension (systolic BP >180 mm Hg or diastolic BP >110 mm Hg) who needed an\n             immediate adjustment of treatment,\n\n          -  Renal insufficiency with serum creatinine >180 \u03bcmol/L or glomerular filtration rate\n             <40 mL/min calculated by the Modification of Diet in Renal Disease formula,15\n             hyperkalemia >5.4 mmol/L, hyponatremia <130 mmol/L, and porphyria;\n\n          -  Pregnant or lactating women or women of fertile age not using effective\n             contraception;\n\n          -  Patients with known prior hypersensitivity to the drug Verospiron (spironolactone;\n             Richter Gedeon Ltd) or who are currently using any aldosterone antagonist."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "79", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02124473", 
            "org_study_id": "Mac/NMP 1120"
        }, 
        "intervention": [
            {
                "arm_group_label": "Homeopathy", 
                "intervention_name": "Homeopathy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Resistant hypertension", 
            "Homeopathy", 
            "Blood pressure", 
            "Ambulatory blood pressure monitoring"
        ], 
        "lastchanged_date": "April 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Jaipur", 
                        "country": "India", 
                        "state": "Rajasthan", 
                        "zip": "302019"
                    }, 
                    "name": "NMP Medical Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jhunjhunu", 
                        "country": "India", 
                        "state": "Rajasthan"
                    }, 
                    "name": "NMP Medical Research Institute"
                }
            }
        ], 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Homeopathy in Resistant Arterial Hypertension", 
        "other_outcome": [
            {
                "measure": "Serum levels of sodium", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in Serum level of sodium at 3 months"
            }, 
            {
                "measure": "Serum levels of potassium", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in serum levels of potassium at 3months"
            }, 
            {
                "measure": "Serum levels of creatinine", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline in Serum levels of creatinine at 3 months"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "NMP Medical Research Institute, India", 
                "last_name": "Vipin Sharma, BHMS", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Macmillan Research Group UK", 
                "last_name": "Neha Sharma", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Daytime systolic and diastolic pressure", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in Systolic and Diastolic Blood Pressure at 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02124473"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "24-hour systolic and diastolic BP", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in 24-hour blood pressure at 3 months"
        }, 
        "source": "Macmillan Research Group UK", 
        "sponsors": {
            "collaborator": {
                "agency": "NMP Medical Research Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Macmillan Research Group UK", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}